Lawmakers want to stop politicians from investing in stocks
Should members of Congress and their families abstain from stock trading?


U.S. senators Kirsten Gillibrand (D- NY) and Josh Hawley (R-Mo.) announced plans to introduce a bipartisan ban on members of the federal executive branch and Congress from owning stock in individual companies and blind trusts. The proposed congressional stock trading ban is the latest in a succession of similar measures introduced by lawmakers from both parties.
Efforts to prohibit congressional stock trading have been ramping up over the last year after investigations by The New York Times and The Wall Street Journal revealed the number of lawmakers trading stocks related to the regulatory committees they sat on. About a dozen similar bills have been introduced this year to amend existing government rules for stock trading in Washington under a 2012 law called the STOCK Act. So while a vote on a stock trading ban has failed to make it to the floor, the debate over the ethical implications rages on.
Lawmakers shouldn't be trying to "line their own pockets"
Gillibrand and Hawley proposed the latest bill to ensure that lawmakers are transparent with their constituents and not abusing their positions. It's "critical" for Americans to "know that their elected leaders are putting the public first," said Gillibrand in a statement to The Wall Street Journal, "not looking for ways to line their own pockets." After introducing a similar bill in January, Hawley asserted that members of Congress and their families "shouldn't be using their position to get rich on the stock market."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Rep. Abigail Spanberger (D-Va.), who partnered with Rep. Chip Roy (R-Texas) on another congressional stock trading ban proposal, said the mounting evidence of unethical trading proves a solution is needed. The public continues to "see story after story hit the headlines of members of Congress who bought and sold stock related to" the Silicon Valley Bank collapse, the invasion of Ukraine, and Covid," Spanberger said at a press conference, per Roll Call. "Frankly speaking, whether there was any ill intention or not, the American people think it's outrageous."
Unethical trading could affect how they vote on legislation
The "deep conflicts" created by congressional stock trading are "significant enough" to produce both "corruption" and the "impression among the public of corruption," Sen. Jeff Merkley (D-Ore.) told CNN's "Before the Bell." "For both reasons, that stock trading needs to end." Merkley proposed the Ending Trading and Holdings in Congressional Stocks (ETHICS) Act, prohibiting lawmakers and their families from buying or selling individual stocks. Merkely expressed concern over how the conflicts of interest "might change how they would vote on legislation." Merkely also pointed out the possibility of lawmakers having confidential information that gives them an "unfair advantage."
A ban could make fewer people want to serve as lawmakers
Not everyone is on board with prohibiting congressional stock trading. "This is a free country, last time I heard," Sen. Tommy Tuberville (R-Al) said in a response to a proposed ban in 2022. He believed curtailing lawmakers' ability to participate in stock trading would lead to fewer people running for office. "I think it's ridiculous. They might as well start sending robots up here," he told The Independent. "I think it would really cut back on the amount of people that would want to come up here and serve."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Theara Coleman has worked as a staff writer at The Week since September 2022. She frequently writes about technology, education, literature and general news. She was previously a contributing writer and assistant editor at Honeysuckle Magazine, where she covered racial politics and cannabis industry news.
-
Pope Francis obituary: modernising pontiff who took the Gospel to the margins
In the Spotlight For traditionalist Catholics, Jorge Bergoglio's reforms often seemed to go too far; progressives, though, will demand more of his successor
By The Week UK
-
Novel 'bone collector' caterpillar wears its prey
Speed Read Hawaiian scientists discover a carnivorous caterpillar that decorates its shell with the body parts of dead insects
By Peter Weber, The Week US
-
Judge blocks key part of Trump's elections overhaul
Speed Read Colleen Kollar-Kotelly's decision temporarily bars federal officials from requiring Americans to prove they are citizens to register to vote
By Rafi Schwartz, The Week US
-
IMF sees slump from tariffs, Trump tries to calm markets
Speed Read The International Monetary Fund predicts the U.S. and global economies will slow significantly due to the president's trade war
By Peter Weber, The Week US
-
Corruption: The road to crony capitalism
Feature Trump's tariff pause sent the stock market soaring — was it insider trading?
By The Week US
-
Tariffs: Time for Congress to take over?
Feature Senators introduce a bill that would require any new tariffs to be approved by Congress
By The Week US
-
'This division is not merely economic; it is also ideological'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US
-
Why did Donald Trump U-turn on tariffs?
Today's Big Question President's 'easy-win' trade war couldn't survive the realities of the US economy
By Jamie Timson, The Week UK
-
Could Trump's tariff war be his undoing with the GOP?
TODAY'S BIG QUESTION The catastrophic effects of the president's 'Liberation Day' tariffs might create a serious wedge between him and the rest of the Republican party
By Rafi Schwartz, The Week US
-
Trump calls tariffs 'medicine' as stocks plunge
Speed Read 'Sometimes you have to take medicine to fix something,' the president said of his imposed 10% tariffs on imported goods
By Peter Weber, The Week US
-
'In a fight, spectacle matters'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US